Physician

Matthew Michael Koehler, DO

According to 2025 Medicare claims, Matthew Koehler, DO (NPI: 1801090519) practices dermatology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is REGENTS UNIV OF CALIFORNIA UCSF (NPI: 1124439807; TIN: 943281662) and primary practice location at 94903-4184.

Koehler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,001 traditional Medicare patients, billed 5,571 HCPCS/CPT codes, and received $276,328 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 1,024 prescription claims across 478 beneficiaries totaling $258,540 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 31 records totaling $697. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $53,876 to $276,328. Similarly, Part D prescription costs have moved sharply higher in recent years, from $52,801 to $258,540. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$138K$276K2016 Medicare payment: $53,876 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $159,650 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $189,711 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $202,736 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $194,089 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $228,381 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $227,490 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $248,518 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $276,328 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20161571,080$53,876
20176393,747$159,650
20187014,149$189,711
20197134,353$202,736
20206314,288$194,089
20217024,984$228,381
20227244,973$227,490
20239065,056$248,518
20241,0015,571$276,328

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$129K$259K2015 Drug cost: $52,801 (USD; Tot_Drug_Cst)2016 Drug cost: $40,017 (USD; Tot_Drug_Cst)2017 Drug cost: $37,633 (USD; Tot_Drug_Cst)2018 Drug cost: $35,413 (USD; Tot_Drug_Cst)2019 Drug cost: $86,723 (USD; Tot_Drug_Cst)2020 Drug cost: $89,474 (USD; Tot_Drug_Cst)2021 Drug cost: $172,213 (USD; Tot_Drug_Cst)2022 Drug cost: $187,225 (USD; Tot_Drug_Cst)2023 Drug cost: $175,047 (USD; Tot_Drug_Cst)2024 Drug cost: $258,540 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015168452$52,801
2016218570$40,017
2017270584$37,633
2018247571$35,413
2019285580$86,723
2020298767$89,474
2021297715$172,213
2022289703$187,225
2023383866$175,047
20244781,024$258,540

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more160160$88
11102Biopsy of related skin growth, first growth170183$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7201,041$73
17000Destruction of precancer skin growth, 1 growth549751$45
17003Destruction of precancer skin growth, 2-14 growths4432,492$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab491,344$183,172
MetronidazoleMetronidazole611,942$3,885
FluorouracilFluorouracil531,659$3,178
Clobetasol PropionateClobetasol Propionate521,549$2,552
KetoconazoleKetoconazole1053,131$1,957

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$697Lilly USA, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Michael Koehler, DO?

Tedicare shows public-source Medicare data for Matthew Michael Koehler, DO (NPI 1801090519), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Michael Koehler, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Michael Koehler, DO?

Matthew Michael Koehler, DO is linked to REGENTS UNIV OF CALIFORNIA UCSF (billing NPI 1124439807) in the available physician profile data.

Does Matthew Michael Koehler, DO have Open Payments data?

Matthew Michael Koehler, DO has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.